Exane Derivatives Constellation Brands, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Constellation Brands, Inc. stock. As of the latest transaction made, Exane Derivatives holds 160 shares of STZ stock, worth $20,665. This represents 0.02% of its overall portfolio holdings.
Number of Shares
160
Previous 163
1.84%
Holding current value
$20,665
Previous $37,000
-0.0%
% of portfolio
0.02%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding STZ
# of Institutions
1,273Shares Held
141MCall Options Held
5.77MPut Options Held
7.01M-
Vanguard Group Inc Valley Forge, PA18.2MShares$2.35 Billion0.04% of portfolio
-
Warren Buffett Berkshire Hathaway Inc | Omaha, Ne13.4MShares$1.73 Billion0.69% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$1.34 Billion0.06% of portfolio
-
Capital World Investors Los Angeles, CA6.68MShares$863 Million0.13% of portfolio
-
State Street Corp Boston, MA6.58MShares$850 Million0.03% of portfolio
About CONSTELLATION BRANDS, INC.
- Ticker STZ
- Exchange NYSE
- Sector Consumer Defensive
- Industry Beverages—Wineries & Distilleries
- Shares Outstandng 161,224,000
- Market Cap $20.8B
- Description
- Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It provides beer primarily under the Corona Extra, Corona Premier, Corona Familiar, Corona Light, Corona Refresca, Corona Hard Seltzer, Modelo Especial, Modelo Neg...